FundingPublic signal16 days ago
What changed
Raised $251M in Series D funding, led by Lux Capital and Natural Capital.
The company said the funding supports increase its flight cadence, deepen its pharmaceutical partnerships, and move closer to delivering the first medicine made in space.
What nextincrease its flight cadence, deepen its pharmaceutical partnerships, and move closer to delivering the first medicine made in space.
Where help may be relevant AfterRaise intelligenceDistribution partnersImplementation partnersAlliances leadership
Approach preferences not yet specified